tiprankstipranks
Tianjin Pharma Unveils 2024 Shareholder-Centric Plan
Company Announcements

Tianjin Pharma Unveils 2024 Shareholder-Centric Plan

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.

Don't Miss our Black Friday Offers:

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has announced its 2024 Action Plan focused on improving quality, efficiency, and prioritizing shareholder returns, in line with the State Council’s directives and the Shanghai Stock Exchange’s initiative. The plan aims to ensure the company’s high-quality development and enhance value for shareholders. The Board takes full responsibility for the announcement’s accuracy and completeness.

For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Singapore Auto-Generated NewsdeskTianjin Pharmaceutical Announces A-Share Adjustments
TipRanks Singapore Auto-Generated NewsdeskTianjin Pharmaceutical Completes Key Milestone in Incentive Scheme
TipRanks Singapore Auto-Generated NewsdeskTianjin Pharmaceutical Announces Corporate Amendments
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App